Atrial Fibrillation Trial, Recruiting NCT06253000 Sponsor: Bakulev Scientific Center of Cardiovascular Surgery Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06253000
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have atrial fibrillation (an irregular heart rhythm) that has not responded to medication designed to control heart rhythm
  • People who have a persistent or long-standing persistent form of atrial fibrillation (meaning the irregular heart rhythm does not stop on its own and has lasted for an extended period)
  • People who have given their consent to take part in the study

Who may not be able to join:

  • People who are under 18 or over 80 years of age
  • People who have another heart condition that requires surgical treatment
  • People who have a heart defect that was present from birth
  • People who have previously had open-heart surgery
  • People who have a disease affecting the bone marrow
  • People who have a condition affecting how their blood clots
  • People whose heart is not pumping strongly enough (the heart's pumping function is below 40%) (confirm with trial site)
  • People with moderate to severe kidney problems where the kidneys are not filtering blood efficiently enough (confirm with trial site)
  • People with high blood pressure that cannot be controlled even with blood pressure medication
  • People who have structural damage or disease of the mitral valve (a valve in the heart)
  • People where there is reason to believe they would not be able to attend follow-up visits during the study
  • People who are currently participating in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrey Filatov, Bakulev Scientific Center for Cardiovascular Surgery

Phone: +7(495) 414-77-02

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bakulev Scientific Center of Cardiovascular Surgery
Registry
ClinicalTrials.gov
Start date
10 June 2023
Est. completion
30 December 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Cerebral events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov